The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.
Year: 2009
Type: article
Abstract: Antiretroviral therapy programs in Africa are currently providing treatment for almost two million people. The long-term success of large scale antiretroviral therapy programs in sub-Saharan Africa remains uncertain because of the limited information currently available on rates of virologic failure and selection for drug-resistant variants in the different HIV subtypes. This article provides a comprehensive review of the published literature on the prevalence of primary and secondary HIV drug resistance with different subtypes and in various settings across sub-Saharan Africa.
Source: PubMed
Authors: Hakim Sendagire, Philippa J Easterbrook, Immaculate Nankya, Eric Arts, David Thomas, Steven J Reynolds
Institution: Infectious Diseases Institute
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Institutes of Health
OpenAlex ID: W2395838540